|
67
|
240
|
5l5fC |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
58
|
204
|
5l64I |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
62
|
231
|
5l62E |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
63
|
231
|
5l69E |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
71
|
240
|
5l5yC |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
61
|
195
|
5laiJ |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
63
|
222
|
5l67L |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
64
|
233
|
5le5D |
Native human 20s proteasome at 1.8 angstrom |
|
61
|
233
|
5lf6D |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
58
|
195
|
5l5aJ |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
64
|
241
|
5l5wG |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
|
66
|
250
|
5l66A |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bortezomib |
|
67
|
244
|
5lajB |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
71
|
243
|
5l63F |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
59
|
222
|
5l5rL |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
64
|
241
|
5l5rG |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
61
|
222
|
5laiL |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
60
|
196
|
5l5yN |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
68
|
211
|
5laiK |
Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
|
70
|
239
|
5lezF |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
64
|
211
|
5m2bK |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
69
|
244
|
5l5eB |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
60
|
222
|
5l5zL |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
58
|
226
|
5lajH |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
100
|
308
|
4z5yA |
The 1.56-angstrom crystal structure of copper(ii)-bound pqqb from pseudomonas putida |
|
59
|
196
|
5l5sN |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
69
|
250
|
5lajA |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
55
|
196
|
5lf4J |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
59
|
195
|
5l5dJ |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
67
|
233
|
5l5tM |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
67
|
242
|
5l63D |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
62
|
220
|
5lf0H |
Human 20s proteasome complex with epoxomicin at 2.4 angstrom |
|
70
|
244
|
5l55B |
Yeast 20s proteasome in complex with epoxyketone inhibitor 18 |
|
66
|
240
|
5l5tC |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
69
|
242
|
5l5jD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
70
|
244
|
5l6bB |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
69
|
212
|
5lajK |
Ligand-induced lys33-thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
|
67
|
213
|
5lf6L |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
61
|
226
|
5l5rH |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
64
|
241
|
5l6aG |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
55
|
204
|
5leyI |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
65
|
241
|
5l5jG |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
71
|
244
|
5l5hB |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
67
|
242
|
5l5xD |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
59
|
226
|
5lttH |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
68
|
242
|
5l67D |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
67
|
240
|
5l67C |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
60
|
234
|
5lf6E |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
66
|
231
|
5l5aE |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
63
|
231
|
5l5sE |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with pr-924 |
